1 |
Grumbach M, Styne D. Puberty : ontogeny, neuroendocrinology, physiology, and disorders. In : Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinololgy. 10th ed. Philadelphia : WB Saunders Co, 2003:1202-40
|
2 |
Rice A, Rivkees SA. Receptor transduction of hormone action. In : Sperling MA, editor. Pediatric endocrinology. 2nd ed. Philadelphia : WB Saunders Co, 2002:33-63
|
3 |
Shankar RR, Pescovitz OH. Precocious puberty. Adv Endocrinol Metab 1995;6:55-89
|
4 |
Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75:292-7
DOI
|
5 |
Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, et al. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty : the Dutch experience. J Pediatr Endocrinol Metab 2000;13 Suppl 1:765-72
DOI
|
6 |
Saggese G, Pasquino AM, Bertelloni S, Baroncelli GI, Battini R, Pucarelli I, et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 1995;84:299-304
DOI
ScienceOn
|
7 |
Bassi F, Bartolini O, Neri AS, Gheri RG, Bucciantini S, Cheli D, et al. Precocious puberty : auxological criteria discriminating different forms. J Endocrinol Invest 1994;17:793-7
DOI
|
8 |
Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after longterm treatment with LHRH agonists : the National Institutes of Health experience. J Clin Endocrinol Metab 2000;86: 4711-6
DOI
|
9 |
Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty : final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84:4583-90
DOI
|
10 |
Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, et al. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 1985;61:152-9.
DOI
|
11 |
Antoniazzi F, Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, et al. End results in central precocious puberty with GnRH analog treatment : the data of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13 Suppl 1:773-80
|
12 |
Oostdijk W, Drop SL, Odink RJ, Hummelink R, Partsch CJ, Sippell WG. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Acta Paediatr Scand Suppl 1991;372:39-45
|
13 |
Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, et al. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonisttreated children with precocious puberty. J Clin Endocrinol Metab 1991;72:301-7
DOI
|
14 |
Paul D, Conte FA, Grumbach MM, Kaplan SL. Long term effect of gonadotropin-releasing hormone agonist therapy on final and nearfinal height in 26 children with true precocious puberty treated at a median age of less then 5 years. J Clin Endocrinol Metab 1995;80:546-51
DOI
|
15 |
Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Metab 1999;84:449-52
DOI
|
16 |
DiMartino-Nardi J, Wu R, Varner R, Wong WL, Saenger P. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein. J Clin Endocrinol Metab 1994;78:664-8
DOI
|
17 |
Tato L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, et al. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment. Horm Res 1995;44 Suppl 3:49-54
DOI
|
18 |
Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994;79:415-20
DOI
|
19 |
Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB Jr. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr Suppl 1993;388:62-8
|
20 |
Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R. Suppression of the pituitary-gonadal axis in children with central precocious puberty : effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion. J Clin Endocrinol Metab 1991;73:734-8
DOI
|
21 |
Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J, Skakkebaek NE. Serum insulin-like growth factor I(IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty : effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen(cyproterone acetate). J Clin Endocrinol Metab 1995;80:3059-67
DOI
|
22 |
Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998;157:363-7
DOI
|